AGX.NYSEArgan INC

Form 4: ARGAN CEO Exercises, Sells 5,000 Shares

Sentiment:

Insider Transaction Report


ARGAN Inc.'s CEO, Charles Edwin Collins IV, exercised stock options and simultaneously sold 5,000 common shares for a significant profit.

Summary

  • Charles Edwin Collins IV, Chief Executive Officer of GEMMA and an officer of ARGAN Inc. (AGX), reported transactions in the company's common stock.
  • On October 1, 2025, he exercised a portion of his stock option, awarded on September 12, 2018, to purchase 5,000 shares of ARGAN common stock at an exercise price of $43.10 per share.
  • Concurrently, on October 1, 2025, he sold 5,000 shares of ARGAN common stock on the open market at an average price of $275 per share.
  • The exercised options were part of an award that became exercisable on September 12, 2019, and is set to expire on September 12, 2028.
  • Following these transactions, Collins directly owns 21,006 shares of ARGAN common stock and 34,735 derivative securities (options).

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction where an executive exercised stock options and sold shares for personal liquidity. This is a common occurrence and does not inherently indicate a positive or negative sentiment for the company's operational performance or future prospects. The executive realized a significant profit, which is positive for the individual.

Positives

  • The reporting person realized a substantial profit from exercising options at $43.10 and selling shares at $275, indicating a strong return on the option grant.
  • The transaction demonstrates the value of the company's equity compensation plan for its executives.

Negatives

  • An insider sale, even if part of an option exercise for liquidity, could be perceived by some investors as a minor negative signal, though it is a common practice.

Future Outlook

NA

Industry Context

This is a routine insider transaction for an executive exercising stock options and selling shares for liquidity, common across all industries for publicly traded companies. It does not provide specific insights into broader industry trends for ARGAN Inc.

Stakeholder Impact

  • Shareholders: May view the insider sale as a neutral event for liquidity or potentially a minor negative signal, though it's a common practice.
  • Employees: No direct impact on employees is indicated by this filing.
  • Management: The CEO realized a significant personal gain from the exercise and sale of shares, demonstrating the value of the company's equity compensation.

Key Dates

DateDescription
09/12/2018Date the stock option was awarded to the Reporting Person.
09/12/2019Date the stock option became exercisable.
10/01/2025Date of option exercise and common stock sale transactions.
10/03/2025Date the Form 4 was filed.
09/12/2028Expiration date of the stock option.

Keywords

ARGAN Inc., AGX, Charles Edwin Collins IV, CEO, Insider Trading, Form 4, Stock Options, Share Sale, Equity Compensation, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.